Hunan Fangsheng Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 831.16 million compared to CNY 852.37 million a year ago. Revenue was CNY 855.22 million compared to CNY 873.31 million a year ago.

Net income was CNY 106.71 million compared to CNY 63.2 million a year ago. Basic earnings per share from continuing operations was CNY 0.25 compared to CNY 0.15 a year ago. Diluted earnings per share from continuing operations was CNY 0.25 compared to CNY 0.15 a year ago.